IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)

The purpose of the IDeA-CTR initiative is to expand the capacity for clinical and translational research in IDeA-eligible states/jurisdictions and to enhance the competitiveness of the investigators to obtain extramural funding for clinical and translational research. This Funding Opportunity Announcement (FOA) provides cooperative agreement support for statewide and/or interstate regional networks to achieve the following objectives: * to support the development and/or enhancement of infrastructure and human resources required to address clinical and translational research needs in IDeA-eligible states/jurisdictions, * to strengthen clinical and translational research that addresses the broad spectrum of health challenges faced by populations in IDeA-eligible states/jurisdictions, * to foster and coordinate collaboration in clinical and translational research within an IDeA-CTR network and with other institutions. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities are not eligible to apply.